Rxivist logo

Author: Kathrin U. Jansen

  • Most recently observed institution: Pfizer Vaccines Research & Development

Rankings

  • All-time downloads: 568,564 (rank: 43 )
  • Categories:
    • immunology: 94,494 (rank: 98 (tie) )
    • infectious diseases: 456,362 (rank: 44 (tie) )
    • microbiology: 7,881 (rank: 2,824 (tie) )

Downloads per author, site-wide

Preprints

Six Month Safety and Efficacy of the BNT162b2 mRNA COVID-19 Vaccine

infectious diseases more details view paper
  • Downloaded 259,417 times
  • Download rankings, all-time:
    • Site-wide: 17
    • In infectious diseases: 9
  • Year to date:
    • Site-wide: 42
  • Since beginning of last month:
    • Site-wide: 69

A prefusion SARS-CoV-2 spike RNA vaccine is highly immunogenic and prevents lung infection in non-human primates

immunology more details view paper
  • Downloaded 94,598 times
  • Download rankings, all-time:
    • Site-wide: 86
    • In immunology: 2
  • Year to date:
    • Site-wide: 119
  • Since beginning of last month:
    • Site-wide: 105

RNA-Based COVID-19 Vaccine BNT162b2 Selected for a Pivotal Efficacy Study

infectious diseases more details view paper
  • Downloaded 84,310 times
  • Download rankings, all-time:
    • Site-wide: 103
    • In infectious diseases: 39
  • Year to date:
    • Site-wide: 450
  • Since beginning of last month:
    • Site-wide: 604

Phase 1/2 Study to Describe the Safety and Immunogenicity of a COVID-19 RNA Vaccine Candidate (BNT162b1) in Adults 18 to 55 Years of Age: Interim Report

infectious diseases more details view paper
  • Downloaded 74,368 times
  • Download rankings, all-time:
    • Site-wide: 117
    • In infectious diseases: 46
  • Year to date:
    • Site-wide: 1,071
  • Since beginning of last month:
    • Site-wide: 1,468

Concurrent human antibody andTH1 type T-cell responses elicited by a COVID-19 RNA vaccine

infectious diseases more details view paper
  • Downloaded 25,065 times
  • Download rankings, all-time:
    • Site-wide: 441
    • In infectious diseases: 164
  • Year to date:
    • Site-wide: 6,132
  • Since beginning of last month:
    • Site-wide: 10,239

BNT162b2 induces SARS-CoV-2-neutralising antibodies and T cells in humans

infectious diseases more details view paper
  • Downloaded 19,099 times
  • Download rankings, all-time:
    • Site-wide: 599
    • In infectious diseases: 221
  • Year to date:
    • Site-wide: 1,140
  • Since beginning of last month:
    • Site-wide: 1,379

Neutralization of Omicron SARS-CoV-2 by 2 or 3 doses of BNT162b2 vaccine

microbiology more details view paper
  • Downloaded 5,631 times
  • Download rankings, all-time:
    • Site-wide: 2,904
    • In microbiology: 222
  • Year to date:
    • Site-wide: 280
  • Since beginning of last month:
    • Site-wide: 11,189

BNT162b vaccines are immunogenic and protect non-human primates against SARS-CoV-2

immunology more details view paper
  • Downloaded 3,572 times
  • Download rankings, all-time:
    • Site-wide: 5,505
    • In immunology: 222
  • Year to date:
    • Site-wide: 12,507
  • Since beginning of last month:
    • Site-wide: 27,828

BNT162b2-Elicited Neutralization of Delta Plus, Lambda, and Other Variants

microbiology more details view paper
  • Downloaded 1,637 times
  • Download rankings, all-time:
    • Site-wide: 17,742
    • In microbiology: 993
  • Year to date:
    • Site-wide: 65,569
  • Since beginning of last month:
    • Site-wide: 94,763

Neutralization of Omicron sublineages and Deltacron SARS-CoV-2 by 3 doses of BNT162b2 vaccine or BA.1 infection

microbiology more details view paper
  • Downloaded 867 times
  • Download rankings, all-time:
    • Site-wide: 47,884
    • In microbiology: 2,929
  • Year to date:
    • Site-wide: 4,388
  • Since beginning of last month:
    • Site-wide: 152,167

PanLingua

News